Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2409837)

Published in Br J Cancer on August 02, 2004

Authors

M Fiegl1, A Massoner, M Haun, W Sturm, H Kaufmann, R Hack, J Krugmann, M Fritzer-Szekeres, K Grünewald, G Gastl

Author Affiliations

1: Division of Haematology and Oncology, Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria. michael.fiegl@uibk.ac.at

Articles cited by this

Care of patients with ascites. N Engl J Med (1994) 4.46

International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer (1999) 4.16

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res (2002) 3.54

Clinical practice. Pleural effusion. N Engl J Med (2002) 3.52

The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med (1992) 2.40

Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Clin Cancer Res (2003) 2.06

Cytologically proved malignant pleural effusions. Chest (1998) 1.26

Pleural effusion in breast carcinoma: analysis of 122 cases. Cancer (1981) 1.13

The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol (1987) 1.12

Transudative pleural effusions: false reassurance against malignancy. Chest (2000) 1.06

Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology (1991) 1.05

Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab Invest (2002) 1.02

Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood (1995) 0.98

Transudative malignant pleural effusions: prevalence and mechanisms. South Med J (1998) 0.97

Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer (1996) 0.94

The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer. J Thorac Cardiovasc Surg (1997) 0.94

Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Hum Pathol (2000) 0.93

Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat Res (1995) 0.93

Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol (1999) 0.93

Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study. Diagn Cytopathol (2001) 0.92

Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions. J Clin Oncol (2004) 0.87

Statistical methods in interphase cytogenetics: an experimental approach. Cytometry (1993) 0.86

Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest (1997) 0.86

Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes. Anal Quant Cytol Histol (1994) 0.84

Treatment of leptomeningeal metastases evaluated by interphase cytogenetics. J Clin Oncol (2000) 0.83

Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol (1998) 0.81

Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions. Br J Cancer (1999) 0.81

Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis. Clin Cancer Res (2002) 0.80

Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH). Cytometry (1999) 0.80

Improving tumor cell detection in pleural effusions by interphase cytogenetics. Cytometry B Clin Cytom (2003) 0.79

Immunocytochemical analysis of ascitic fluid due to cirrhosis. A contribution to understanding the origin of markedly atypical cells. Acta Cytol (1992) 0.78

Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission. Leukemia (1999) 0.78

FISH in the evaluation of pleural and ascitic fluids. Cancer Genet Cytogenet (1995) 0.78

Malignant-appearing cells in pleural effusion due to pancreatitis: case report and literature review. Acta Cytol (1981) 0.77

Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization. Am J Pathol (1996) 0.77

Articles by these authors

Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27

Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01

Two G protein oncogenes in human endocrine tumors. Science (1990) 4.46

Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet (2000) 3.18

Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors. Lancet (2001) 2.77

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res (1996) 2.40

New approach in strabismus surgery in high myopia. Br J Ophthalmol (1997) 2.23

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (1999) 2.17

Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet (2000) 1.94

Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet (2000) 1.86

Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71

The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol (1997) 1.70

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood (2000) 1.64

High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer (2008) 1.56

Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med (1994) 1.55

Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med (1993) 1.54

RFLP maps of potato and their alignment with the homoeologous tomato genome. Theor Appl Genet (1991) 1.49

Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status. Br J Haematol (1997) 1.46

Lea symbols: visual acuity assessment and detection of amblyopia. Graefes Arch Clin Exp Ophthalmol (2000) 1.40

[Comments on the medical aspects of out-patient surgical interventions]. Klin Monbl Augenheilkd (2004) 1.37

Epidemiology of reflex syncope. Clin Auton Res (2004) 1.37

Investigation of a self-compatible mutation in Solanum tuberosum clones inhibiting S-allele activity in pollen differentially. Mol Gen Genet (1991) 1.33

TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol (2008) 1.32

Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc Natl Acad Sci U S A (2008) 1.31

Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol (2001) 1.27

Elucidation of restrictive motility in high myopia by magnetic resonance imaging. Arch Ophthalmol (1997) 1.25

Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25

Adhesion and invasion of bovine endothelial cells by Neospora caninum. Parasitology (1996) 1.23

Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. J Clin Pathol (2006) 1.23

Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology (2000) 1.23

Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins. Biochemistry (1973) 1.23

Examination of young children with Lea symbols. Br J Ophthalmol (2002) 1.22

Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion. Leukemia (2006) 1.22

Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol (2007) 1.20

Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer (1997) 1.19

Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation (1990) 1.18

Diagnostic value of history taking in reflex syncope. Clin Auton Res (2004) 1.17

Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br J Cancer (2003) 1.16

Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ (1995) 1.16

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents (2010) 1.15

Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest (2000) 1.15

Heterogeneity of erythrocyte catalase. Correlations between sulfhydryl group content, chromatographic and electrophoretic properties. Eur J Biochem (1969) 1.15

Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol (2001) 1.14

Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med (1990) 1.14

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo. Br J Cancer (2009) 1.13

Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa. AIDS (1999) 1.12

Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer (2004) 1.11

Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res (1995) 1.10

XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland. Cell Death Differ (2005) 1.09

Effects of blood estrogen level on cortical activation patterns during cognitive activation as measured by functional MRI. Neuroimage (2001) 1.09

Volume of procedures at transplantation centers and mortality after liver transplantation. N Engl J Med (2000) 1.08

Cyclosporin blood levels do correlate with clinical complications. Lancet (1984) 1.07

Large-vessel arteritis and myelodysplastic syndrome: report of two cases. Eur J Haematol (2004) 1.07

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transpl Infect Dis (2007) 1.06

Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure. Clin Auton Res (2001) 1.06

The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels. Pharmacogenomics J (2001) 1.05

Imported malaria: six cases of severe Plasmodium falciparum infection in Innsbruck, Austria, within a period of five weeks (February/March 1999) Wien Klin Wochenschr (2000) 1.05

Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome. J Hum Hypertens (2011) 1.05

Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am J Cardiol (2001) 1.03

A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome. J Exp Med (1992) 1.03

Absence of three regular thyroid arteries replaced by an unusual lowest thyroid artery (A. thyroidea ima): a case report. Surg Radiol Anat (1996) 1.02

The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy. Crit Rev Clin Lab Sci (1997) 1.02

[6-desoxy-L-idose, 6-desoxy-L-sorbose, and 6-desoxy-L-psicose]. Helv Chim Acta (1967) 1.02

T lymphocytes and plasma inhibitory factor in ACTH-dependent Cushing's patients. Clin Immunol Immunopathol (1979) 1.02

Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis (1996) 1.01

Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol (1999) 1.01

Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. Acta Neuropathol (2000) 1.00

Impact of alertness training on spatial neglect: a behavioural and fMRI study. Neuropsychologia (2005) 1.00

In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin Exp Immunol (1988) 0.99

The most abundant soluble basic protein of the stylar transmitting tract in potato (Solanum tuberosum L.) is an endochitinase. Planta (1994) 0.99

Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol (1996) 0.98

The amino-terminal peptide of alpha-1-acid glycoprotein. J Biol Chem (1966) 0.98

Primary autonomic failure: three clinical presentations of one disease? Ann Intern Med (2000) 0.98

Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology (2000) 0.98

Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells. Blood (1997) 0.98

Toxicology and hazard potential of trifluralin. Food Chem Toxicol (1992) 0.97

Hematopoietic stem cells. Biomed Pharmacother (2001) 0.97

Breath acetone-aspects of normal physiology related to age and gender as determined in a PTR-MS study. J Breath Res (2009) 0.96

Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT). Br J Haematol (1987) 0.96

Surgery for nystagmus related head turn: Kestenbaum procedure and artificial divergence. Graefes Arch Clin Exp Ophthalmol (2001) 0.96

Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics. J Antibiot (Tokyo) (2001) 0.96

[The course of pregnancy in a representative Swiss sample (Aarau Pregnancy and Newborn Infant Study). II. Stimulants in pregnancy]. Schweiz Med Wochenschr (1985) 0.95

Differential activity of P-glycoprotein in normal blood lymphocyte subsets. Br J Haematol (1998) 0.95

Isolation and partial characterization of the cyanogen bromide fragments of 1 -acid glycoprotein and the elucidation of the amino acid sequence of the carboxyl-terminal cyanogen bromide fragment. Biochemistry (1972) 0.94

Violacein cytotoxicity and induction of apoptosis in V79 cells. In Vitro Cell Dev Biol Anim (2000) 0.94

Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J Clin Oncol (1989) 0.93

Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc Res (2001) 0.93

Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Hum Pathol (2000) 0.93

Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol (2001) 0.93

Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis. Ann Hematol (2001) 0.93

Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects. Br J Cancer (1998) 0.92

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. J Clin Oncol (2000) 0.92

Malignant pericardial mesotheliomas and asbestos exposure: a case report. Am J Ind Med (1982) 0.91

[Notes on a modification of Cüpper's Faden operation (the "false faden") (author's transl)]. Klin Monbl Augenheilkd (1981) 0.91

Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Am Heart J (1993) 0.91

Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol (1991) 0.90